| 标题 |
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 studyFurmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | doi: 10.1016/S2213-2600(22)00168-0 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
fantasy
奋斗易真
不潮薯饼
OK
Kao
Zephyrite
Nole
小小牛马
14and15
斯文的初蝶
无极微光
潇洒的惋清
Zzzz
Copyright
初景
斯文钢笔
老胡
儒雅的板栗
失眠的觅翠
皖公网安备34019202002308
